173 related articles for article (PubMed ID: 21489980)
1. Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism.
Nocchi L; Tomasetti M; Amati M; Neuzil J; Santarelli L; Saccucci F
J Biol Chem; 2011 Jun; 286(22):19478-88. PubMed ID: 21489980
[TBL] [Abstract][Full Text] [Related]
2. [Expression of thrombomodulin in malignant pleural mesothelioma].
Amati M; Nocchi I; Tomasetti M; Santarelli L; Saccucci F
G Ital Med Lav Ergon; 2011; 33(3 Suppl):99-102. PubMed ID: 23393812
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the thrombomodulin gene in human malignant melanoma.
Furuta J; Kaneda A; Umebayashi Y; Otsuka F; Sugimura T; Ushijima T
Melanoma Res; 2005 Feb; 15(1):15-20. PubMed ID: 15714116
[TBL] [Abstract][Full Text] [Related]
4. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity.
Zampieri M; Passananti C; Calabrese R; Perilli M; Corbi N; De Cave F; Guastafierro T; Bacalini MG; Reale A; Amicosante G; Calabrese L; Zlatanova J; Caiafa P
PLoS One; 2009; 4(3):e4717. PubMed ID: 19262751
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer.
Bi FF; Li D; Yang Q
BMC Cancer; 2013 Feb; 13():90. PubMed ID: 23442605
[TBL] [Abstract][Full Text] [Related]
6. PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1.
Pinton G; Manente AG; Murer B; De Marino E; Mutti L; Moro L
J Cell Mol Med; 2013 Feb; 17(2):233-41. PubMed ID: 23301673
[TBL] [Abstract][Full Text] [Related]
7. Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis.
Tomasetti M; Amati M; Nocchi L; Saccucci F; Strafella E; Staffolani S; Tarquini LM; Carbonari D; Alleva R; Borghi B; Neuzil J; Bracci M; Santarelli L
Mutagenesis; 2011 Sep; 26(5):585-91. PubMed ID: 21543585
[TBL] [Abstract][Full Text] [Related]
8. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation regulates thrombomodulin in high altitude induced deep vein thrombosis.
Vijay A; Jha PK; Parveen S; Goel S; Prabhakar A; Sharma S; Kumar B; Chatterjee T; Bajaj N; Nair V; Sharma M; Ashraf MZ
Thromb Res; 2022 Jul; 215():5-13. PubMed ID: 35580466
[TBL] [Abstract][Full Text] [Related]
11. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression.
Gao A; Zuo X; Liu Q; Lu X; Guo W; Tian L
Toxicol Lett; 2010 Jun; 195(2-3):114-8. PubMed ID: 20230882
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
15. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
Samlowski WE; Leachman SA; Wade M; Cassidy P; Porter-Gill P; Busby L; Wheeler R; Boucher K; Fitzpatrick F; Jones DA; Karpf AR
J Clin Oncol; 2005 Jun; 23(17):3897-905. PubMed ID: 15753459
[TBL] [Abstract][Full Text] [Related]
17. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
18. Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer.
Li D; Bi FF; Cao JM; Cao C; Li CY; Liu B; Yang Q
Oncotarget; 2014 Jan; 5(1):291-7. PubMed ID: 24448423
[TBL] [Abstract][Full Text] [Related]
19. Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.
Gong Y; Guo MZ; Ye ZJ; Zhang XL; Zhao YL; Yang YS
World J Gastroenterol; 2011 Jan; 17(4):526-33. PubMed ID: 21274384
[TBL] [Abstract][Full Text] [Related]
20. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
